Yentreve



Indications and Reactions:

Role Indications Reactions
Primary
Stress Urinary Incontinence 33.1%
Urinary Incontinence 14.7%
Product Used For Unknown Indication 10.3%
Incontinence 5.1%
Stress Incontinence 5.1%
Pain 3.7%
Depression 2.9%
Psychotic Disorder 2.9%
Asthma 2.2%
Gastrooesophageal Reflux Disease 2.2%
Hormone Replacement Therapy 2.2%
Hypertension 2.2%
Menopause 2.2%
Palpitations 2.2%
Cardiac Failure 1.5%
Fibromyalgia 1.5%
Hypercholesterolaemia 1.5%
Mood Swings 1.5%
Nasopharyngitis 1.5%
Rhinitis 1.5%
Tremor 11.1%
Accidental Drug Intake By Child 7.4%
Nausea 7.4%
Vomiting 7.4%
Circulatory Collapse 5.6%
Ventricular Extrasystoles 5.6%
Vision Blurred 5.6%
Weight Increased 5.6%
Fall 3.7%
Myocardial Ischaemia 3.7%
Panic Attack 3.7%
Paraesthesia 3.7%
Poor Quality Sleep 3.7%
Pulmonary Oedema 3.7%
Serotonin Syndrome 3.7%
Suicidal Ideation 3.7%
Syncope 3.7%
Urine Output Decreased 3.7%
Visual Disturbance 3.7%
Weight Decreased 3.7%
Secondary
Product Used For Unknown Indication 39.8%
Stress Urinary Incontinence 26.5%
Drug Use For Unknown Indication 9.6%
Anxiety 3.6%
Fibromyalgia 3.6%
Palpitations 3.6%
Urinary Incontinence 3.6%
Hormone Replacement Therapy 2.4%
Nasopharyngitis 2.4%
Depression 1.2%
Micturition Urgency 1.2%
Rheumatoid Arthritis 1.2%
Surgery 1.2%
Suicidal Ideation 12.1%
Ventricular Extrasystoles 12.1%
Vertigo 9.1%
Vision Blurred 9.1%
Circulatory Collapse 6.1%
Fatigue 6.1%
Poor Quality Sleep 6.1%
Suicide Attempt 6.1%
Urine Output Decreased 6.1%
Vomiting 6.1%
Amnesia 3.0%
Glutamate Dehydrogenase Increased 3.0%
Macular Oedema 3.0%
Mania 3.0%
Social Avoidant Behaviour 3.0%
Stupor 3.0%
Tonsil Cancer 3.0%
Concomitant
Restless Legs Syndrome 17.1%
Micturition Urgency 12.2%
Osteoporosis 9.8%
Prophylaxis 9.8%
Hypertension 7.3%
Rheumatoid Arthritis 7.3%
Urinary Tract Infection 7.3%
Bone Disorder 4.9%
Depression 4.9%
Micturition Disorder 4.9%
Osteoporosis Postmenopausal 4.9%
Diabetes Mellitus 2.4%
Incontinence 2.4%
Osteoarthritis 2.4%
Urinary Incontinence 2.4%
Chills 22.2%
Fall 22.2%
Amnesia 11.1%
Loss Of Consciousness 11.1%
Pulmonary Oedema 11.1%
Tonsil Cancer 11.1%
Urinary Tract Infection 11.1%
Interacting
Hypertension 42.9%
Incontinence 28.6%
Atrial Fibrillation 14.3%
Prostate Cancer 14.3%
Hypotension 50.0%
Necrosis 50.0%